Bliss GVS Pharma

Bliss GVS Pharma, a smallcap pharmaceutical company, has recently hit a 52-week high with its stock price reaching Rs.179.65 on December 13, 2024. The stock has been performing well in the market, outperforming its sector by 3.64% on the same day. This marks the second consecutive day of gains for the company, with a 17.64% increase in its stock price in the past two days. The stock's intraday high was recorded at Rs.179.65, showing a 3.51% increase, while the intraday low was at Rs.165.2, with a decrease of 4.81%. Bliss GVS Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market. In the past year, Bliss GVS Pharma has shown a strong performance with a 34.39% increase in its stock price, while the Sensex has only seen a 17.81% increase. This showcases the company's growth and potential in the pharmaceutical industry. With its recent performance and positive outlook, Bliss GVS Pharma is definitely a company to watch out for in the smallcap pharmaceutical sector.